Skip to main content

Advertisement

Log in

Pentoxifylline, tocopherol, and sequestrectomy are effective for the management of advanced osteoradionecrosis of the jaws—a case series

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

The aim of the present study was to evaluate the efficacy of pentoxifylline and tocopherol for the management of osteoradionecrosis of the jaws.

Methods

Twenty-five patients diagnosed with osteoradionecrosis of the jaws treated with pentoxifylline 400 mg + tocopherol 400 mg three times daily (tid) were evaluated. Clinical records and image tests were reviewed. All patients were previously submitted to head and neck radiation therapy and presented with a clinical and radiographic diagnosis of osteoradionecrosis of the jaws.

Results

Following therapy with pentoxifylline and tocopherol, 76% (19/25) of the patients showed complete mucosal healing, in which 47.3% (9/19) did not undergo sequestrectomy. From this particular group, 77.7% (7/9) were in stage I and 33.3% (3/9) used the protocol for up to 3 months. Among those who underwent to sequestrectomy, complete mucosal healing was observed in 52.7% (10/19). Among these, 60% (6/10) were in stage I and 100% of the patients were using the protocol for more than 3 months. In all other patients, partial healing of the mucosa was observed since they presented advanced disease. These represented 24% of the sample (6/25), 66.6% (4/6) were in stage III, and 60% (4/6) used the protocol for over 6 months.

Conclusion

Pentoxifylline and tocopherol may provide effective management of osteoradionecrosis of the jaws, and the association with sequestrectomy may avoid major surgical procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ribeiro ILA, Medeiros JJ, Rodrigues LV, Valença AMG, Neto EAL (2015) Fatores associados ao câncer de lábio e cavidade oral. Rev Bras Epidemiol 18(3):618–629

    Article  Google Scholar 

  2. Instituto Nacional De Câncer José Alencar Gomes Da Silva (INCA) - Coordenação de Prevenção e Vigilância (2018) Estimativa 2018: incidência de câncer no Brasil. https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-incidencia-de-cancer-no-brasil-2018.pdf Access on September 25, 2019

  3. Patel V, McGurk M (2017) Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy. Br J Oral Maxillofac Surg 55(3):235–241

    Article  CAS  Google Scholar 

  4. Santos RCS, Dias RS, Giardani AJ, Segreto RA, Segreto HRC (2011) Mucosite em pacientes portadores de câncer de cabeça e pescoço submetidos à radioterapia e quimioterapia. Rev Esc Enferm USP 45(6):1338–1344

    Article  Google Scholar 

  5. Shin DM, Khuri FR (2011) Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck 35(3):443–453

    Article  Google Scholar 

  6. Koyfman SA, Brizel DM, Posner MR (2019) General principles of radiation therapy for head and neck cancer. UpToDate

  7. Nabil S, Samman N (2011) Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg 40(3):229–243

    Article  CAS  Google Scholar 

  8. Moura JFB, Lima RP (2015) Tumores de cabeça e pescoço - Radioterapia em oncologia. Atheneu, São Paulo, pp 505–515

    Google Scholar 

  9. Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H (2017) The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber/Brigham and Women’s Cancer Center Multidisciplinary Guideline. Oncologist 22(3):343–350

    Article  CAS  Google Scholar 

  10. Ramli R, Ngeow WC, Rahman RA, Chai WL (2006) Managing complications of radiation therapy in head and neck cancer patients: part IV. Management of osteoradionecrosis. Singap Dent J 28(1):11–15

    Google Scholar 

  11. Lyons A, Ghazali N (2008) Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg 46(8):653–660

    Article  Google Scholar 

  12. Pitak-Arnnop P, Sader R, Dhanuthai K, Masaratana P, Bertolus C, Chaine A, Bertrand JC, Hemprich A (2008) Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol 34(10):1123–1134

    Article  CAS  Google Scholar 

  13. Lyons A, Brennan P (2017) Pentoxifylline – a review of its use in osteoradionecrosis. Br J Oral Maxillofac Surg 55(3):230–234

    Article  CAS  Google Scholar 

  14. Delanian S, Lefaix JL (2000) Refractory osteoradionecrosis: striking healing with a combination of pentoxifylline-tocopherol. Abstract presented at 19th annual ESTRO Meeting, Istanbul. Radiother Oncol 56:129

    Article  Google Scholar 

  15. Delanian S, Depondt J, Lefaix JL (2005) Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 27(2):114–123

    Article  Google Scholar 

  16. Patel V, Gadiwalla Y, Sassoon I, Sproat C, Kwok J, McGurk M (2016) Use of pentoxifylline and tocopherol in the management of osteoradionecrosis. Br J Oral Maxillofac Surg 54(3):342–345

    Article  Google Scholar 

  17. Kolokythas A, Rasmussen JT, Reardon J, Feng C (2019) Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis. Int Oral Maxillofac Surg 48(2):173–180

    Article  CAS  Google Scholar 

  18. Hamama S, Delanian S, Monceau V, Vozenib MC (2012) Therapeutic management of intestinal fibrosis induced by radiation therapy: from molecular profiling to new intervention strategies et vice et versa. Fibrogenesis Tissue Repair 5(1):13

    Article  Google Scholar 

  19. Raoul G, Maes JM, Pasquier D, Nicola J, Ferri J (2005) Ostéoradionécrose des maxillaires (maxillaire et mandibulaire). EMC-Stomatologie 1(4):255–276

    Article  Google Scholar 

  20. Instituto Nacional De Câncer José Alencar Gomes Da Silva (INCA) - Coordenação de Prevenção e Vigilância. Estimativa 2016: incidência de câncer no Brasil. http://santacasadermatoazulay.com.br/wp-content/uploads/2017/06/estimativa-2016-v11.pdf Access on September 25, 2019

  21. Teng MS, Futran ND (2005) Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg 13(4):217–221

    Article  Google Scholar 

  22. Chronopoulos A, Zarra T, Ehrenfeld M, Otto S (2017) Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J 68(1):22–30

    Article  Google Scholar 

  23. Rice N, Polyzois I, Ekanayake K, Omer O, Leo FA, Stassen A (2015) The management of osteoradionecrosis of the jaws—a review. Surgeon 13(2):101–109

    Article  Google Scholar 

  24. Marx RE, Johnson RP (1987) Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 64(4):379–390

    Article  CAS  Google Scholar 

  25. Aldunate B, Coltro OS, Busnardo FF, Ferreira MC (2010) Osteorradionecrose em face: fisiopatologia, diagnóstico e tratamento. Rev Bras Cir Plást 25(2):381–387

    Google Scholar 

  26. Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, Nakamura M (2003) Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 25(3):181–186

    Article  Google Scholar 

  27. Chronopoulos A (2015) Clinical presentation and risk factors of osteoradionecrosis. Doctoral dissertation, LMU München: Faculty of Medicine

  28. Li YX, Weber-Johnson K, Sun LQ, Paschoud N, Mirimanoff RO, Coucke PA (1998) Effect of pentoxifylline on radiation induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells. Radiat Res 149(4):338–342

    Article  CAS  Google Scholar 

  29. Gude RP, Binda MM, Boquete AL, Bonfil RD (2001) Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline. J Cancer Res Clin Oncol 127(10):625–630

    Article  CAS  Google Scholar 

  30. Lang T, Johanning K, Metzler H, Piepenbock S, Solomon C, Rahe-Meyer N, Tanaka KA (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analog 108(3):751–758

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Igor Henrique Morais Silva.

Ethics declarations

Conflict of interest

There was no funding for this research. The costs were covered by the main researcher. There is full control of all primary data and we allow the journal to review the data if requested.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

dos Anjos, R.S., de Pádua Walfrido, G.N., de Hollanda Valente, R.O. et al. Pentoxifylline, tocopherol, and sequestrectomy are effective for the management of advanced osteoradionecrosis of the jaws—a case series. Support Care Cancer 29, 3311–3317 (2021). https://doi.org/10.1007/s00520-020-05847-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05847-6

Keywords

Navigation